{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:48Z","timestamp":1792787868417,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sophiahemmet University College","id":[{"id":"https:\/\/ror.org\/01aem0w72","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Treatments in the phase of metastatic castration-resistant prostate cancer (mCRPC) aim to prolong survival and reduce the symptom burden. The fast development of life-prolonging therapies makes treatment decision-making (TDM) complex, weighting survival against possible side-effects and quality of life, especially in a real-world context. This study aimed to describe satisfaction with TDM at start of the first, second and third line of life-prolonging treatment and to describe and compare long-term treatment experiences when receiving one or several lines of treatment in patients with mCRPC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A longitudinal observational study. Participants completed a study-specific questionnaire every three months for up to two years from the start of any first line of life-prolonging treatment after mCRPC. Satisfaction with TDM was measured at the start of each new treatment line while treatment experiences were measured using the first and last completed questionnaire of each participant. Medical data was obtained from medical records. Descriptive statistics were used to present data while inferential statistics were used for analysis of group comparisons and over time changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 122 participants (mean age 75.3 years) with an average follow-up time of 18.3 months were included. Satisfaction with TDM was generally high at the start of the first, second and third line of treatment, but lower regarding discussions on how treatment could affect their life situation. Treatment experiences were positive, yet there was a significant decrease from the first to the last follow-up in whether they would choose (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04) and recommend (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01) the same treatment to others. For participants who received one line of treatment, a significant decrease was found between the first and the last follow-up (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02), while no differences were found for those who received two or more lines.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite high satisfaction with aspects of TDM and the treatment given it is important to discuss how the treatment can impact the patient\u2019s life situation. The slightly decreased satisfaction over time on the treatment received could reflect a possible need to strengthen communication between patients and healthcare professionals, shifting from a disease-centered perspective towards a more person-centered and palliative care approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12904-026-02336-1","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:53:38Z","timestamp":1789779218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Satisfaction with treatment decision-making and long-term experiences of life-prolonging treatments for metastatic castration-resistant prostate cancer"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7158-7790","authenticated-orcid":false,"given":"Paula","family":"Routier Ca\u00f1igueral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Wennman-Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Doveson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"R\u00f6nning\u00e5s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"2336_CR1","doi-asserted-by":"publisher","unstructured":"Shickh S, Leventakos K, Lewis MA, Bombard Y, Montori VM. Shared Decision Making in the Care of Patients With Cancer. Am Soc Clin Oncol Educ Book. 2023;43e389516. https:\/\/doi.org\/10.1200\/EDBK_389516.","DOI":"10.1200\/EDBK_389516"},{"issue":"12","key":"2336_CR2","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1177\/0193945917723010","volume":"40","author":"K Kim","year":"2018","unstructured":"Kim K, Heinze K, Xu J, Kurtz M, Park H, Foradori M, et al. Theories of Health Care Decision Making at the End of Life: A Meta-Ethnography. West J Nurs Res. 2018;40(12):1861\u201384. https:\/\/doi.org\/10.1177\/0193945917723010.","journal-title":"West J Nurs Res"},{"issue":"2","key":"2336_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1037\/a0036834","volume":"70","author":"VF Reyna","year":"2015","unstructured":"Reyna VF, Nelson WL, Han PK, Pignone MP. Decision making and cancer. Am Psychol. 2015;70(2):105\u201318. https:\/\/doi.org\/10.1037\/a0036834.","journal-title":"Am Psychol"},{"issue":"3","key":"2336_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11912-022-01203-5","volume":"24","author":"A An","year":"2022","unstructured":"An A, Hui D. Immunotherapy Versus Hospice: Treatment Decision-Making in the Modern Era of Novel Cancer Therapies. Curr Oncol Rep. 2022;24(3):285\u201394. https:\/\/doi.org\/10.1007\/s11912-022-01203-5.","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"2336_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jgo.2020.08.001","volume":"12","author":"S Rostoft","year":"2021","unstructured":"Rostoft S, van den Bos F, Pedersen R, Hamaker ME. Shared decision-making in older patients with cancer - What does the patient want? J Geriatr Oncol. 2021;12(3):339\u201342. https:\/\/doi.org\/10.1016\/j.jgo.2020.08.001.","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"2336_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/curroncol30010061","volume":"30","author":"C Cincidda","year":"2023","unstructured":"Cincidda C, Pizzoli SFM, Ongaro G, Oliveri S, Pravettoni G. Caregiving and Shared Decision Making in Breast and Prostate Cancer Patients: A Systematic Review. Curr Oncol. 2023;30(1):803\u201323. https:\/\/doi.org\/10.3390\/curroncol30010061.","journal-title":"Curr Oncol"},{"key":"2336_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2147\/ppa.S334827","volume":"16","author":"FA Schumacher","year":"2022","unstructured":"Schumacher FA, Helenowski IB, Oswald LB, Gonzalez BD, Benning JT, Morgans AK. Treatment Decision-Making in Metastatic Prostate Cancer: Perceptions of Locus of Control Among Patient, Caregiver, and Physician Triads. Patient Prefer Adherence. 2022;16:235\u201344. https:\/\/doi.org\/10.2147\/ppa.S334827.","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"2336_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2336_CR9","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00345-023-04416-w","volume":"41","author":"C Lejeune","year":"2023","unstructured":"Lejeune C, Bourredjem A, Binquet C, Cussenot O, Boudrant G, Papillon F, et al. Eliciting men\u2019s preferences for decision-making relative to treatments of localized prostate cancer with a good or moderate prognosis. World J Urol. 2023;41(6):1541\u20139. https:\/\/doi.org\/10.1007\/s00345-023-04416-w.","journal-title":"World J Urol"},{"issue":"7","key":"2336_CR10","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/pon.5054","volume":"28","author":"A Shrestha","year":"2019","unstructured":"Shrestha A, Martin C, Burton M, Walters S, Collins K, Wyld L. Quality of life versus length of life considerations in cancer patients: A systematic literature review. Psychooncology. 2019;28(7):1367\u201380. https:\/\/doi.org\/10.1002\/pon.5054.","journal-title":"Psychooncology"},{"issue":"10","key":"2336_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11934-019-0924-2","volume":"20","author":"J Shevach","year":"2019","unstructured":"Shevach J, Weiner A, Morgans AK. Quality of Life-Focused Decision-Making for Prostate Cancer. Curr Urol Rep. 2019;20(10):57. https:\/\/doi.org\/10.1007\/s11934-019-0924-2.","journal-title":"Curr Urol Rep"},{"issue":"2","key":"2336_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jgo.2016.01.001","volume":"7","author":"Y Ged","year":"2016","unstructured":"Ged Y, Horgan AM. Management of castrate-resistant prostate cancer in older men. J Geriatr Oncol. 2016;7(2):57\u201363. https:\/\/doi.org\/10.1016\/j.jgo.2016.01.001.","journal-title":"J Geriatr Oncol"},{"key":"2336_CR13","doi-asserted-by":"publisher","first-page":"100962","DOI":"10.1016\/j.drup.2023.100962","volume":"68","author":"M Cai","year":"2023","unstructured":"Cai M, Song XL, Li XA, Chen M, Guo J, Yang DH, et al. Current therapy and drug resistance in metastatic castration-resistant prostate cancer. Drug Resist Updat. 2023;68:100962. https:\/\/doi.org\/10.1016\/j.drup.2023.100962.","journal-title":"Drug Resist Updat"},{"issue":"6","key":"2336_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40271-024-00702-w","volume":"17","author":"C Navas","year":"2024","unstructured":"Navas C, Minton AP, Rodriguez-Leboeuf AM. The Role of Patient-Reported Outcomes to Measure Treatment Satisfaction in Drug Development. Patient. 2024;17(6):603\u201317. https:\/\/doi.org\/10.1007\/s40271-024-00702-w.","journal-title":"Patient"},{"issue":"4","key":"2336_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.eururo.2020.01.012","volume":"77","author":"S Gillessen","year":"2020","unstructured":"Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, et al. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol. 2020;77(4):508\u201347. https:\/\/doi.org\/10.1016\/j.eururo.2020.01.012.","journal-title":"Eur Urol"},{"key":"2336_CR16","doi-asserted-by":"publisher","first-page":"1240864","DOI":"10.3389\/fonc.2023.1240864","volume":"13","author":"D Leaning","year":"2023","unstructured":"Leaning D, Kaur G, Morgans AK, Ghouse R, Mirante O, Chowdhury S. Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews. Front Oncol. 2023;13:1240864. https:\/\/doi.org\/10.3389\/fonc.2023.1240864.","journal-title":"Front Oncol"},{"issue":"1","key":"2336_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41391-023-00647-5","volume":"26","author":"FA Schumacher","year":"2023","unstructured":"Schumacher FA, Helenowski IB, Sun Z, Oswald LB, Gonzalez BD, Moses KA, et al. Treatment decision-making among patients with metastatic prostate cancer: Impact of decision locus of control on functional outcomes and decision satisfaction. Prostate Cancer Prostatic Dis. 2023;26(1):201\u20136. https:\/\/doi.org\/10.1038\/s41391-023-00647-5.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"2336_CR18","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1007\/s00520-021-06753-1","volume":"30","author":"S Pan","year":"2022","unstructured":"Pan S, Mao J, Wang L, Dai Y, Wang W. Patient participation in treatment decision-making of prostate cancer: a qualitative study. Support Care Cancer. 2022;30(5):4189\u2013200. https:\/\/doi.org\/10.1007\/s00520-021-06753-1.","journal-title":"Support Care Cancer"},{"issue":"10437","key":"2336_CR19","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James ND, Tannock I, N\u2019Dow J, Feng F, Gillessen S, Ali SA, et al. The <\u2009em>Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683\u2013722. https:\/\/doi.org\/10.1016\/S0140-6736(24)00651-2.","journal-title":"Lancet"},{"issue":"1","key":"2336_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12957-025-03937-5","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Tang M, Shao J, Li S, Teng Y, Xu Y, et al. Global, regional, and national burden and trends of prostate cancer in elderly from 1990 to 2021: results from global burden of disease 2021. World J Surg Oncol. 2025;23(1):303. https:\/\/doi.org\/10.1186\/s12957-025-03937-5.","journal-title":"World J Surg Oncol"},{"issue":"3","key":"2336_CR21","doi-asserted-by":"publisher","first-page":"E160","DOI":"10.5489\/cuaj.6521","volume":"15","author":"A El-Haouly","year":"2021","unstructured":"El-Haouly A, Dragomir A, El-Rami H, Liandier F, Lacasse A. Treatment decision-making in men with localized prostate cancer living in a remote area: A cross-sectional, observational study. Can Urol Assoc J. 2021;15(3):E160\u20138. https:\/\/doi.org\/10.5489\/cuaj.6521.","journal-title":"Can Urol Assoc J"},{"key":"2336_CR22","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.2147\/ppa.S271620","volume":"14","author":"LB Oswald","year":"2020","unstructured":"Oswald LB, Schumacher FA, Gonzalez BD, Moses KA, Penson DF, Morgans AK. What Do Men with Metastatic Prostate Cancer Consider When Making Treatment Decisions? A Mixed-methods Study. Patient Prefer Adherence. 2020;14:1949\u201359. https:\/\/doi.org\/10.2147\/ppa.S271620.","journal-title":"Patient Prefer Adherence"},{"key":"2336_CR23","volume-title":"Experiences, expectations and treatment decision-making in men with metastatic prostate cancer [Doctoral thesis, comprehensive summary]","author":"S Doveson","year":"2022","unstructured":"Doveson S. Experiences, expectations and treatment decision-making in men with metastatic prostate cancer [Doctoral thesis, comprehensive summary]. Stockholm: Karolinska Institutet; 2022."},{"key":"2336_CR24","volume-title":"Experiences of signs and symptoms among men with advanced prostate cancer [PhD]","author":"U Ronningas","year":"2022","unstructured":"Ronningas U. Experiences of signs and symptoms among men with advanced prostate cancer [PhD]. Stockholm, Sweden: Karolinska Institutet; 2022."},{"issue":"3","key":"2336_CR25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/jco.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570\u20139. https:\/\/doi.org\/10.1200\/jco.1993.11.3.570.","journal-title":"J Clin Oncol"},{"key":"2336_CR26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.2340\/1651-226x.2025.42748","volume":"64","author":"S Doveson","year":"2025","unstructured":"Doveson S, Fransson P, Axelsson L, Wennman-Larsen A. Treatment decision-making and treatment experiences in men with metastatic castration-resistant prostate cancer. Acta Oncol. 2025;64:462\u20139. https:\/\/doi.org\/10.2340\/1651-226x.2025.42748.","journal-title":"Acta Oncol"},{"key":"2336_CR27","doi-asserted-by":"publisher","unstructured":"On behalf of the European Organisation for R, Treatment of Cancer Quality of Life G, Quality of, Life U, Br\u00e9dart A, Bottomley A, Blazeby JM et al. An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32). European Journal of Cancer. 2005;41(14):2120-31 https:\/\/doi.org\/10.1016\/j.ejca.2005.04.041.","DOI":"10.1016\/j.ejca.2005.04.041"},{"issue":"3","key":"2336_CR28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s11136-013-0520-8","volume":"23","author":"JD Peipert","year":"2014","unstructured":"Peipert JD, Beaumont JL, Bode R, Cella D, Garcia SF, Hahn EA. Development and validation of the functional assessment of chronic illness therapy treatment satisfaction (FACIT TS) measures. Qual Life Res. 2014;23(3):815\u201324. https:\/\/doi.org\/10.1007\/s11136-013-0520-8.","journal-title":"Qual Life Res"},{"issue":"2","key":"2336_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cptl.2020.09.005","volume":"13","author":"MD Wolcott","year":"2021","unstructured":"Wolcott MD, Lobczowski NG. Using cognitive interviews and think-aloud protocols to understand thought processes. Currents Pharm Teach Learn. 2021;13(2):181\u20138. https:\/\/doi.org\/10.1016\/j.cptl.2020.09.005.","journal-title":"Currents Pharm Teach Learn"},{"key":"2336_CR30","doi-asserted-by":"publisher","DOI":"10.4135\/9781412986038","volume-title":"Summated rating scale construction: an introduction","author":"PE Spector","year":"1992","unstructured":"Spector PE. Summated rating scale construction: an introduction. Newbury Park: Sage; 1992."},{"key":"2336_CR31","unstructured":"Machin D, Walters SJ, Campbell MJ. Medical statistics: a textbook for the health sciences. Fifth edition ed: Wiley-Blackwell; 2021 2021. 433 sidor p."},{"issue":"6","key":"2336_CR32","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1111\/hex.13822","volume":"26","author":"M Edwards","year":"2023","unstructured":"Edwards M, Holland-Hart D, Mann M, Seddon K, Buckle P, Longo M, et al. Understanding how shared decision-making approaches and patient aids influence patients with advanced cancer when deciding on palliative treatments and care: A realist review. Health Expect. 2023;26(6):2109\u201326. https:\/\/doi.org\/10.1111\/hex.13822.","journal-title":"Health Expect"},{"issue":"2","key":"2336_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ctrv.2014.12.010","volume":"41","author":"MTE Puts","year":"2015","unstructured":"Puts MTE, Tapscott B, Fitch M, Howell D, Monette J, Wan-Chow-Wah D, et al. A systematic review of factors influencing older adults\u2019 decision to accept or decline cancer treatment. Cancer Treat Rev. 2015;41(2):197\u2013215. https:\/\/doi.org\/10.1016\/j.ctrv.2014.12.010.","journal-title":"Cancer Treat Rev"},{"key":"2336_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ejca.2023.02.018","volume":"185","author":"S Gillessen","year":"2023","unstructured":"Gillessen S, Bossi A, Davis ID, de Bono J, Fizazi K, James ND, et al. Management of patients with advanced prostate cancer-metastatic and\/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022. Eur J Cancer. 2023;185:178\u2013215. https:\/\/doi.org\/10.1016\/j.ejca.2023.02.018.","journal-title":"Eur J Cancer"},{"key":"2336_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1200\/go.20.00511","volume":"7","author":"FC Maluf","year":"2021","unstructured":"Maluf FC, Pereira FMT, Silva AG, Dettino ALA, Cardoso APG, Sasse AS, et al. Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC). JCO Global Oncol. 2021;7:559\u201371. https:\/\/doi.org\/10.1200\/go.20.00511.","journal-title":"JCO Global Oncol"},{"key":"2336_CR36","doi-asserted-by":"publisher","first-page":"101859","DOI":"10.1016\/j.ejon.2020.101859","volume":"49","author":"S Doveson","year":"2020","unstructured":"Doveson S, Holm M, Axelsson L, Fransson P, Wennman-Larsen A. Facing life-prolonging treatment: The perspectives of men with advanced metastatic prostate cancer - An interview study. Eur J Oncol Nurs. 2020;49:101859. https:\/\/doi.org\/10.1016\/j.ejon.2020.101859.","journal-title":"Eur J Oncol Nurs"},{"issue":"5","key":"2336_CR37","doi-asserted-by":"publisher","first-page":"101763","DOI":"10.1016\/j.jgo.2024.101763","volume":"15","author":"KFT Jochems","year":"2024","unstructured":"Jochems KFT, Menges D, Sanchez D, de Glas NA, Wildiers H, Eberli D, et al. Outcomes in studies regarding older patients with prostate cancer: A systematic review. J Geriatr Oncol. 2024;15(5):101763. https:\/\/doi.org\/10.1016\/j.jgo.2024.101763.","journal-title":"J Geriatr Oncol"},{"key":"2336_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejca.2019.04.031","volume":"116","author":"HJ Boyle","year":"2019","unstructured":"Boyle HJ, Alibhai S, Decoster L, Efstathiou E, Fizazi K, Mottet N, et al. Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients. Eur J Cancer. 2019;116:116\u201336. https:\/\/doi.org\/10.1016\/j.ejca.2019.04.031.","journal-title":"Eur J Cancer"},{"key":"2336_CR39","doi-asserted-by":"publisher","unstructured":"Kadambi S, Kehoe L, Wells M, Patil A, Lei L, Lewis-Thames MW, et al. I have a doctor that handles all the other stuff. Perceptions of older adults with cancer about discussing aging-related conditions with their oncologists. J Geriatr Oncol. 2024;102065. https:\/\/doi.org\/10.1016\/j.jgo.2024.102065.","DOI":"10.1016\/j.jgo.2024.102065"},{"issue":"4","key":"2336_CR40","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jpainsymman.2020.04.027","volume":"60","author":"L Radbruch","year":"2020","unstructured":"Radbruch L, De Lima L, Knaul F, Wenk R, Ali Z, Bhatnaghar S, et al. Redefining Palliative Care-A New Consensus-Based Definition. J Pain Symptom Manage. 2020;60(4):754\u201364. https:\/\/doi.org\/10.1016\/j.jpainsymman.2020.04.027.","journal-title":"J Pain Symptom Manage"},{"issue":"8","key":"2336_CR41","doi-asserted-by":"publisher","first-page":"e1357","DOI":"10.1200\/op.21.00377","volume":"18","author":"GT Wasp","year":"2022","unstructured":"Wasp GT, Knutzen KE, Murray GF, Brody-Bizar OC, Liu MA, Pollak KI, et al. Systemic Therapy Decision Making in Advanced Cancer: A Qualitative Analysis of Patient-Oncologist Encounters. JCO Oncol Pract. 2022;18(8):e1357\u201366. https:\/\/doi.org\/10.1200\/op.21.00377.","journal-title":"JCO Oncol Pract"},{"issue":"12","key":"2336_CR42","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1080\/0284186X.2022.2153621","volume":"61","author":"M Szilcz","year":"2022","unstructured":"Szilcz M, Wastesson JW, Morin L, Calder\u00f3n-Larra\u00f1aga A, Lambe M, Johnell K. Potential overtreatment in end-of-life care in adults 65 years or older dying from cancer: applying quality indicators on nationwide registries. Acta Oncol. 2022;61(12):1437\u201345. https:\/\/doi.org\/10.1080\/0284186X.2022.2153621.","journal-title":"Acta Oncol"},{"issue":"9","key":"2336_CR43","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.1007\/s00520-022-07150-y","volume":"30","author":"J Bergqvist","year":"2022","unstructured":"Bergqvist J, Hedman C, Schultz T, Strang P. Equal receipt of specialized palliative care in breast and prostate cancer: a register study. Support Care Cancer. 2022;30(9):7721\u201330. https:\/\/doi.org\/10.1007\/s00520-022-07150-y.","journal-title":"Support Care Cancer"},{"key":"2336_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.12703\/p6-33","volume":"6","author":"ER Kessler","year":"2014","unstructured":"Kessler ER, Flaig TW. Geriatric considerations in the treatment of advanced prostate cancer. F1000Prime Rep. 2014;6:33. https:\/\/doi.org\/10.12703\/p6-33.","journal-title":"F1000Prime Rep"},{"issue":"3","key":"2336_CR45","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jpainsymman.2017.11.009","volume":"55","author":"PE Perez-Cruz","year":"2018","unstructured":"Perez-Cruz PE, Shamieh O, Paiva CE, Kwon JH, Muckaden MA, Bruera E, et al. Factors Associated With Attrition in a Multicenter Longitudinal Observational Study of Patients With Advanced Cancer. J Pain Symptom Manage. 2018;55(3):938\u201345. https:\/\/doi.org\/10.1016\/j.jpainsymman.2017.11.009.","journal-title":"J Pain Symptom Manage"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-026-02336-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-026-02336-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-026-02336-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:07:43Z","timestamp":1789780063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12904-026-02336-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2336"],"URL":"https:\/\/doi.org\/10.1186\/s12904-026-02336-1","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was granted ethical approval by the Swedish Ethical Review Authority, Dnr 2014\/341-21\/2, Dnr 2016\/851-32 and Dnr 2016\/2230-32 and was performed in compliance with the ethical principles for medical research involving human participants from the Declaration of Helsinki. Written informed consent was obtained from all the participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"278"}}